Brief: Solvonis Therapeutics Signs MoU With Portugal's National Addiction Institute
13/10/2026 07:44
BRIEF-Solvonis Therapeutics Signs MoU With Portugal's National Addiction Institute Oct 13 (Reuters) - Solvonis Therapeutics PLC SVNS.L:
SOLVONIS THERAPEUTICS - SIGNS MOU WITH PORTUGAL'S NATIONAL ADDICTION INSTITUTE FOR SVN-001 PHASE 3 TRIAL EXPANSION
Source text: ID:nRSM6317Ya
Further company coverage: SVNS.L
((Reuters.Briefs@thomsonreuters.com))